Search research articles
Contact Us
Filters
Showing results (241-250 of 269) with videos related to
Page
of 27
Sort By:
Journal of Crohn'S & Colitis
|
September 30, 2017
Effect of PF-00547659 on Central Nervous System Immune Surveillance and Circulating β7+ T Cells in Crohn's Disease: Report of the TOSCA Study
Geert D'Haens, Séverine Vermeire, Harald Vogelsang, et al.
Gastroenterology
|
February 12, 2020
Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn's Disease
William J Sandborn, Brian G Feagan, Edward V Loftus, et al.
JAMA
|
April 10, 2008
Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC Randomized Controlled Trials
Brian G Feagan, William J Sandborn, Ulrich Mittmann, et al.
Lancet (London, England)
|
November 4, 2017
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial
Jean-Frederic Colombel, Remo Panaccione, Peter Bossuyt, et al.
Gastroenterology
|
January 11, 2018
Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn's Disease
Geert D'Haens, Severine Vermeire, Guy Lambrecht, et al.
Gastroenterology
|
March 27, 2013
The role of centralized reading of endoscopy in a randomized controlled trial of mesalamine for ulcerative colitis
Brian G Feagan, William J Sandborn, Geert D'Haens, et al.
Clinical and Translational Gastroenterology
|
July 29, 2022
Magnetic Resonance Enterography and Histology in Patients With Fibrostenotic Crohn's Disease: A Multicenter Study
Alexandre Coimbra, Jordi Rimola, Miriam Cuatrecasas, et al.
The Cochrane Database of Systematic Reviews
|
September 9, 2017
Placebo response and remission rates in randomised trials of induction and maintenance therapy for ulcerative colitis
Vipul Jairath, G Y Zou, Claire E Parker, et al.
The New England Journal of Medicine
|
July 17, 2024
Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease
Laurent Peyrin-Biroulet, J Casey Chapman, Jean-Frederic Colombel, et al.
Journal of Crohn'S & Colitis
|
July 12, 2023
Discontinuation of Anti-Tumour Necrosis Factor Therapy in Patients with Perianal Fistulizing Crohn's Disease: Individual Participant Data Meta-Analysis of 309 Patients from 12 Studies
Sebastiaan Ten Bokkel Huinink, Doranne Thomassen, Ewout W Steyerberg, et al.
Page
of 27
Search research articles
Search
Showing results (241-250 of 269) with videos related to
Sort By:
Page
of 27
Journal of Crohn'S & Colitis
|
September 30, 2017
Effect of PF-00547659 on Central Nervous System Immune Surveillance and Circulating β7+ T Cells in Crohn's Disease: Report of the TOSCA Study
Geert D'Haens, Séverine Vermeire, Harald Vogelsang, et al.
Gastroenterology
|
February 12, 2020
Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn's Disease
William J Sandborn, Brian G Feagan, Edward V Loftus, et al.
JAMA
|
April 10, 2008
Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC Randomized Controlled Trials
Brian G Feagan, William J Sandborn, Ulrich Mittmann, et al.
Lancet (London, England)
|
November 4, 2017
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial
Jean-Frederic Colombel, Remo Panaccione, Peter Bossuyt, et al.
Gastroenterology
|
January 11, 2018
Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn's Disease
Geert D'Haens, Severine Vermeire, Guy Lambrecht, et al.
Gastroenterology
|
March 27, 2013
The role of centralized reading of endoscopy in a randomized controlled trial of mesalamine for ulcerative colitis
Brian G Feagan, William J Sandborn, Geert D'Haens, et al.
Clinical and Translational Gastroenterology
|
July 29, 2022
Magnetic Resonance Enterography and Histology in Patients With Fibrostenotic Crohn's Disease: A Multicenter Study
Alexandre Coimbra, Jordi Rimola, Miriam Cuatrecasas, et al.
The Cochrane Database of Systematic Reviews
|
September 9, 2017
Placebo response and remission rates in randomised trials of induction and maintenance therapy for ulcerative colitis
Vipul Jairath, G Y Zou, Claire E Parker, et al.
The New England Journal of Medicine
|
July 17, 2024
Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease
Laurent Peyrin-Biroulet, J Casey Chapman, Jean-Frederic Colombel, et al.
Journal of Crohn'S & Colitis
|
July 12, 2023
Discontinuation of Anti-Tumour Necrosis Factor Therapy in Patients with Perianal Fistulizing Crohn's Disease: Individual Participant Data Meta-Analysis of 309 Patients from 12 Studies
Sebastiaan Ten Bokkel Huinink, Doranne Thomassen, Ewout W Steyerberg, et al.
Page
of 27